These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12107856)

  • 1. Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature.
    Azaz-Livshits T; Hershko A; Ben-Chetrit E
    Pharmacopsychiatry; 2002 May; 35(3):112-5. PubMed ID: 12107856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible hepatotoxicity of paroxetine in a patient with major depression.
    Helmchen C; Boerner RJ; Meyendorf R; Hegerl U
    Pharmacopsychiatry; 1996 Nov; 29(6):223-6. PubMed ID: 8956353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe hepatitis attributed to paroxetine (Seroxat)].
    de Man RA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(11):540-2. PubMed ID: 9190513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic hepatitis associated with paroxetine.
    Colakoglu O; Tankurt E; Unsal B; Ugur F; Kupelioglu A; Buyrac Z; Akpinar Z
    Int J Clin Pract; 2005 Jul; 59(7):861-2. PubMed ID: 15963219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxetine and hepatotoxicity.
    Benbow SJ; Gill G
    BMJ; 1997 May; 314(7091):1387. PubMed ID: 9161313
    [No Abstract]   [Full Text] [Related]  

  • 6. Withdrawal after discontinuation of paroxetine.
    Arya DK
    Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
    [No Abstract]   [Full Text] [Related]  

  • 7. Exacerbation of extrapyramidal symptoms with paroxetine.
    Arya DK; McKenzie J; Worrall N
    Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxetine-induced bruxism effectively treated with tandospirone.
    Kishi Y
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):90-1. PubMed ID: 17308240
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alopecia due to Seroxat therapy].
    Umansky L; Dorevitch A; Sella A
    Harefuah; 2000 Apr; 138(7):547-9, 614. PubMed ID: 10883182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akathisia: a review and case report following paroxetine treatment.
    Baldassano CF; Truman CJ; Nierenberg A; Ghaemi SN; Sachs GS
    Compr Psychiatry; 1996; 37(2):122-4. PubMed ID: 8654061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic epidermal necrolysis after paroxetine treatment.
    Ahmed R; Eagleton C
    N Z Med J; 2008 May; 121(1274):86-9. PubMed ID: 18535650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pruritus induced by interruption of paroxetine therapy.
    Mazzatenta C; Peonia G; Martini P
    Br J Dermatol; 2004 Apr; 150(4):787. PubMed ID: 15099390
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of serial nightmares and oneiroid state under paroxetine for senile depression.
    Kobayashi T; Yamauchi M
    Psychogeriatrics; 2012 Mar; 12(1):54-7. PubMed ID: 22416829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].
    Vergouwen AC; Bakker A
    Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ECG changes after paroxetine. 3 case reports].
    Erfurth A; Loew M; Dobmeier P; Wendler G
    Nervenarzt; 1998 Jul; 69(7):629-31. PubMed ID: 9715482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower gastrointestinal bleeding and paroxetine use: two case reports.
    Blasco-Fontecilla H; de Leon J
    Psychosomatics; 2012; 53(2):184-7. PubMed ID: 22424167
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bradycardia after beginning therapy with metoprolol and paroxetine].
    König F; Häfele M; Hauger B; Löble M; Wössner S; Wolfersdorf M
    Psychiatr Prax; 1996 Sep; 23(5):244-5. PubMed ID: 8992519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delirium and multiple electrolyte abnormalities associated with high dose paroxetine exposure.
    Chuang YF; Chiu YL; Hwang TJ; Chu TS
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):642-3. PubMed ID: 16958954
    [No Abstract]   [Full Text] [Related]  

  • 19. Paroxetine: a review of clinical experience.
    Dunner D; Kumar R
    Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible paroxetine-induced symptomatic hypothyroidism.
    Takahashi M; Sawayama E; Sawayama T; Miyaoka H
    Pharmacopsychiatry; 2007 Sep; 40(5):201-2. PubMed ID: 17874352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.